ema glp-1 vision loss recommendation 2025 Does GLP-1 Cause Vision Problems? Evidence and Eye Health Guidance

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025

23.14

★★★★☆4.8 (126)

The metabolic health revolution has arrived

29.31

★★★★★4.9 (98)

Ozempic blindness isn't a real diagnosis. It's a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). The

20.15

★★★★★5.0 (157)

A new study finds that GLP-1 medications—such as Ozempic and Wegovy—may double the risk of developing neovascular age-related macular degeneration (nAMD), a serious eye disease, in older adults with diabetes. Demetrios Vavvas,

23.78

★★★★★4.7 (84)

EMA warns Ozempic linked to 'very rare' side effect

22.89

★★★★★4.9 (203)

A new study is looking at a possible link between certain diabetes medications (GLP-1 receptor agonists) and a rare eye condition called NAION, which can cause sudden vision loss. The research does

20.45

★★★★★5.0 (176)

A new study is looking at a possible link between certain diabetes medications (GLP-1 receptor agonists) and a rare eye condition called NAION, which can cause sudden vision loss. The research does

25.88

★★★★★4.8 (132)